Bristol-Myers Squibb
BMY
$65.16
Share price
-0.49%
Change (1 day)
-14.92%
Change (1 year)
Categories
Bristol-Myers Squibb (BMY) - P/B ratio
P/B ratio as of June 2023 : 4.29
According to Bristol-Myers Squibb's latest financial reports the company has a price-to-book ratio of 4.29.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Bristol-Myers Squibb - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 4.92 | 27.9% |
| 2021-12-31 | 3.84 | 3.88% |
| 2020-12-31 | 3.70 | 33.76% |
| 2019-12-31 | 2.77 | -53.7% |
| 2018-12-31 | 5.98 | -29.42% |
| 2017-12-31 | 8.47 | 41.7% |
| 2016-12-31 | 5.97 | -24.58% |
| 2015-12-31 | 7.92 | 21.64% |
| 2014-12-31 | 6.51 | 13.76% |
| 2013-12-31 | 5.72 | 46.97% |
| 2012-12-31 | 3.90 | 3.5% |
| 2011-12-31 | 3.76 | 30.82% |
| 2010-12-31 | 2.88 | -1.43% |
| 2009-12-31 | 2.92 | -22.38% |
| 2008-12-31 | 3.76 | -24.14% |
| 2007-12-31 | 4.96 | -4.1% |
| 2006-12-31 | 5.17 | 28.81% |
| 2005-12-31 | 4.01 | -17.94% |
| 2004-12-31 | 4.89 | -13.76% |
| 2003-12-31 | 5.67 | 12.42% |
| 2002-12-31 | 5.04 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.36 | 24.94% | 🇺🇸 USA |
 Novartis NVS | 4.00 | -6.73% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.29 | -46.68% | 🇺🇸 USA |
 AbbVie ABBV | 13.9 | 224.49% | 🇺🇸 USA |
 Eli Lilly LLY | 36.7 | 754.26% | 🇺🇸 USA |
 Amgen AMGN | 22.1 | 414.90% | 🇺🇸 USA |
 Sanofi SNY | 1.59 | -63.03% | 🇫🇷 France |
 Biogen BIIB | 3.20 | -25.44% | 🇺🇸 USA |
 Merck MRK | 5.98 | 39.37% | 🇺🇸 USA |
 AstraZeneca AZN | 6.35 | 47.81% | 🇬🇧 UK |